Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,437 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · derivative · entry 7

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,060

Underlying: Common Stock · 1,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F8 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F8 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · derivative · entry 6

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,184

Underlying: Common Stock · 531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Tax withholdingCommon Stock 513 $43.82 $22,479.66
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 4

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,678

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Exercise / conversionCommon Stock 1,437 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 3

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,191

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Tax withholdingCommon Stock 190 $43.82 $8,325.80
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 2

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,754

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Hansen Shannon MarieEVP & Chief Legal Officer
Exercise / conversionCommon Stock 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 1

Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,437 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · derivative · entry 6

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,060

Underlying: Common Stock · 1,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · derivative · entry 5

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,787

Underlying: Common Stock · 596 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 513 $43.82 $22,479.66
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 4

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,543

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 1,437 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 213 $43.82 $9,333.66
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,619

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 5,472 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 9

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,301

Underlying: Common Stock · 5,472 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F8 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F9 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F9 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 8

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,709

Underlying: Common Stock · 2,236 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan, as amended.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 7

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,377

Underlying: Common Stock · 793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 2,774 $43.82 $121,556.68
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 6

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,766

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 5,472 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 5

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 1,134 $43.82 $49,691.88
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 4

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,068

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,202

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 402 $43.82 $17,615.64
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,966

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,503 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 9

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,522

Underlying: Common Stock · 1,503 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F8 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F9 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F9 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 8

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,423

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 7

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 430 $43.82 $18,842.60
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 6

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,372

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 1,503 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 5

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 136 $43.82 $5,959.52
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 4

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,299

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,435

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 47 $43.82 $2,059.54
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,961

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2024 Filed Aug 20, 2024 00:31 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 20:52 UTC
Allen DickDirector
GiftCommon Stock 6,639 $38.89 $258,190.71
Disclosure

SEC source: 0001438133-24-000180 · wk-form4_1723236714.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 22,757

F1 · kind: The shares were given as a bona fide gift.

F2 · price: The price per share reflects the average of the high and low trading prices of Tandem Diabetes Care, Inc. (the Company) stock on the transaction date.

F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:16 UTC
Kyrillos Jean-ClaudeEVP & Chief Operating Officer
GrantRestricted Stock Unit · Derivative 43,634 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000170 · wk-form4_1721247403.xml · derivative · entry 1

Kyrillos Jean-Claude · CIK 0001804186 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,634

Underlying: Common Stock · 43,634 shares

Expires not disclosed

F1 · security: Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F1 · derivative.exercise_price: Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_date: Restricted stock units (RSU) vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F2 · derivative.expiration_date: Restricted stock units (RSU) vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:42 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · derivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,436

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:42 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 145 $45.33 $6,572.85
Disclosure

SEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,236

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:42 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:42 UTC
Cha MyoungilDirector
Exercise / conversionRestricted Stock Unit · Derivative 1,749 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · derivative · entry 2

Cha Myoungil · CIK 0001934068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,749

Underlying: Common Stock · 1,749 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:42 UTC
Cha MyoungilDirector
Exercise / conversionCommon Stock 1,749 $45.33 $79,282.17
Disclosure

SEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · nonDerivative · entry 1

Cha Myoungil · CIK 0001934068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:41 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,749 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000162 · wk-form4_1718916076.xml · derivative · entry 2

Malagueira Joao Paulo Falcao · CIK 0001937552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,749

Underlying: Common Stock · 1,749 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 20:41 UTC Exercise / conversionCommon Stock 1,749 $45.33 $79,282.17
Disclosure

SEC source: 0001438133-24-000162 · wk-form4_1718916076.xml · nonDerivative · entry 1

Malagueira Joao Paulo Falcao · CIK 0001937552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:10 UTC
Allen DickDirector
OtherCommon Stock 9,396 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000155 · wk-form4_1718309434.xml · nonDerivative · entry 2

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 29,396

F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust dated October 12, 1981.

F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:10 UTC
Allen DickDirector
OtherCommon Stock 9,396 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000155 · wk-form4_1718309434.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust dated October 12, 1981.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 21:39 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
OtherCommon Stock 11,749 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000153 · wk-form4_1718228338.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 11,749

F1 · kind: The reported transaction was a transfer of shares from Elizabeth A. Gasser's direct holdings to The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.

F2 · ownership.nature: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 21:39 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
OtherCommon Stock 11,749 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000153 · wk-form4_1718228338.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was a transfer of shares from Elizabeth A. Gasser's direct holdings to The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 22:40 UTC
Allen DickDirector
GiftCommon Stock 1,892 $51.32 $97,097.44
Disclosure

SEC source: 0001438133-24-000150 · wk-form4_1718059204.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 20,000

F1 · kind: The shares were given as a bona fide gift to The Gammon Family Trust, dated April 18, 2000.

F2 · price: The price per share reflects the average of the high and low trading prices of Tandem Diabetes Care, Inc. (the Company) stock on the transaction date.

F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 20:22 UTC
Allen DickDirector
SaleCommon Stock 5,000 $51.68 $258,400.00
Disclosure

SEC source: 0001438133-24-000148 · wk-form4_1717446134.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $51.62 to $51.70.

F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
May 28, 2024 Filed May 28, 2024 18:44 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · derivative · entry 4

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 28, 2024 Filed May 28, 2024 18:44 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 129 $51.73 $6,673.17
Disclosure

SEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,876

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 28, 2024 Filed May 28, 2024 18:44 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,005

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2024 Filed May 28, 2024 22:44 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000139 · wk-form4_1716936246.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 28, 2024 Filed May 28, 2024 22:44 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 134 $51.73 $6,931.82
Disclosure

SEC source: 0001438133-24-000139 · wk-form4_1716936246.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,749

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.